Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Slager

Showing results (211-220 of 277) with videos related to

Pageof 28
Sort By:
Human Molecular Genetics|March 17, 2018
A genome-wide association study of IgM antibody against phosphorylcholine: shared genetics and phenotypic relationship to chronic lymphocytic leukemiaXu Chen, Stefan Gustafsson, Thomas Whitington, et al.
Blood Cancer Journal|April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genesNicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.
Blood|November 17, 2011
A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32Wendy Cozen, Dalin Li, Timothy Best, et al.
British Journal of Haematology|August 27, 2010
Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL familiesLynn R Goldin, Mark C Lanasa, Susan L Slager, et al.
Blood Advances|June 23, 2020
Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significanceAlyssa I Clay-Gilmour, Michelle A T Hildebrandt, Elizabeth E Brown, et al.
International Journal of Cancer|January 2, 2008
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph ConsortiumEleanor V Willett, Lindsay M Morton, Patricia Hartge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2018
Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical TrialsMatthew J Maurer, Hervé Ghesquières, Brian K Link, et al.
British Journal of Haematology|October 3, 2012
Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypesSusan L Slager, Nicola J Camp, Lucia Conde, et al.
International Journal of Epidemiology|April 8, 2024
Design and quality control of large-scale two-sample Mendelian randomization studiesPhilip C Haycock, Maria Carolina Borges, Kimberley Burrows, et al.
Nature Communications|August 8, 2024
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulationMatthew E Stokes, Kerstin Wenzl, C Chris Huang, et al.
Pageof 28

Showing results (211-220 of 277) with videos related to

Sort By:
Pageof 28
Human Molecular Genetics|March 17, 2018
A genome-wide association study of IgM antibody against phosphorylcholine: shared genetics and phenotypic relationship to chronic lymphocytic leukemiaXu Chen, Stefan Gustafsson, Thomas Whitington, et al.
Blood Cancer Journal|April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genesNicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.
Blood|November 17, 2011
A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32Wendy Cozen, Dalin Li, Timothy Best, et al.
British Journal of Haematology|August 27, 2010
Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL familiesLynn R Goldin, Mark C Lanasa, Susan L Slager, et al.
Blood Advances|June 23, 2020
Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significanceAlyssa I Clay-Gilmour, Michelle A T Hildebrandt, Elizabeth E Brown, et al.
International Journal of Cancer|January 2, 2008
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph ConsortiumEleanor V Willett, Lindsay M Morton, Patricia Hartge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2018
Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical TrialsMatthew J Maurer, Hervé Ghesquières, Brian K Link, et al.
British Journal of Haematology|October 3, 2012
Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypesSusan L Slager, Nicola J Camp, Lucia Conde, et al.
International Journal of Epidemiology|April 8, 2024
Design and quality control of large-scale two-sample Mendelian randomization studiesPhilip C Haycock, Maria Carolina Borges, Kimberley Burrows, et al.
Nature Communications|August 8, 2024
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulationMatthew E Stokes, Kerstin Wenzl, C Chris Huang, et al.
Pageof 28